Jiangsu Hengrui Pharma IPO Lockup - US$850m Cornerstone Release
Jiangsu Hengrui Pharmaceuticals (1276 HK), a China-based pharmaceutical company, raised around US$1.5bn in its H-share listing in May 2025. The...
476 Views
Klook Pre-IPO - The Negatives - Disclosures Lagging
Klook (KLK US), a pan-regional experiences platform in Asia-Pacific, aims to raise around US$500m in its US listing. In this note, we talk about...
392 Views
Klook Pre-IPO - The Positives - Growth Has Been Very Strong
Klook (KLK US), a pan-regional experiences platform in Asia-Pacific, aims to raise around US$500m in its US listing. In this note, we talk about...
254 Views
Shenzhen Zhaowei A/H Listing - Autos Thriving but Robotics Driving Share Price
Shenzhen Zhaowei Machinery & Electronics (003021 CH), aims to raise around US$700m in its H-share listing. In this note, we look at the company's...
506 Views
SHEIN Update: US$2 Bn Net, "Mid-Teens" Revenue Growth Targets Shared | New Challenges in France?
Last week, SHEIN reportedly shared FY25 revenue and net income targets with potential investors, which suggests progress towards an IPO. News out...
399 Views